Often irritated, never duplicated
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I guess that explains the major buys...
Kudos to those who added on these lows. Looks like it will pay off nicely.
"I see it as bigger, highly funded..."
Perhaps that's why they would be a great candidate to eventually acquire MMTC, for the right price of course. MMM is indeed huge, but their main products are outside the sector. If they want to expand into food safety products in a big way, doing what is necessary to put the MIT-1000 in their product line would be a smart move.
"if we provided our samples..."
Unless you are qualified to handle such pathogens, you might think twice. Just trying to obtain such samples as an individual is probably enough to get put on a list as a potential bio-terrorist.
I'll take "Rhymes With Salted" for $1000, Alex...
(Humming "Another One Bites the Dust"...)
"...GLAD that possibility exists..."
Concur, unrecognized enterprise value waiting for a proper assessment and corresponding PPS. I flipped early to ride freebies, but may dip into an increased position as things unfold. The DTC list was a red flag to me a few months ago, as was the departure of a key board member, but neither negates the discrepancy between the assets-vs-cap.
Apparently priced on the cheap today, but these micro-caps swing wildly. I'll wait for further carnage to buy more. Tax selling season and the presumed slump that follows increase the odds of low-ball dips.
"...waiting 2 years for salmonelia and Ecoli?"
I seem to recall reading about that. Wasn't there a comment in one of Brennan's interviews that E. Coli had numerous pathogenic strains and the testing was long and detailed before they were ready to apply for certification?
http://en.wikipedia.org/wiki/Escherichia_coli
Escherichia coli encompasses an enormous population of bacteria that exhibit a very high degree of both genetic and phenotypic diversity. Genome sequencing of a large number of isolates of E. coli and related bacteria shows that a taxonomic reclassification would be desirable. However, this has not been done, largely due to its medical importance[25] and Escherichia coli remains one of the most diverse bacterial species: only 20% of the genome is common to all strains.[26] In fact, from the evolutionary point of view, the members of genus Shigella (dysenteriae, flexneri, boydii, sonnei) should be classified as E. coli strains, a phenomenon termed taxa in disguise.[27] Similarly, other strains of E. coli (e.g. the K-12 strain commonly used in recombinant DNA work) are sufficiently different that they would merit reclassification.
A strain is a sub-group within the species that has unique characteristics that distinguish it from other strains. These differences are often detectable only at the molecular level; however, they may result in changes to the physiology or lifecycle of the bacterium. For example, a strain may gain pathogenic capacity, the ability to use a unique carbon source, the ability to take upon a particular ecological niche or the ability to resist antimicrobial agents. Different strains of E. coli are often host-specific, making it possible to determine the source of faecal contamination in environmental samples.[8][9] For example, knowing which E. coli strains are present in a water sample allows researchers to make assumptions about whether the contamination originated from a human, another mammal or a bird.
"...do you really believe that...?"
Having seen the prices over a year ago, I would not have believed that we'd see .0016, but I waited, watched, and grabbed right before the run to .0195.
There is no predicting what manipulations may be employed to shake the tree, given the impending run based on eventual production and revenues. Everyone can see it coming, yet here we sit flirting with 25% of YTD highs. I've seen leverage, in the form of major untapped enterprise value, get thrashed mercilessly by those who wish to weasel out short term gains, or those who think they deserve to buy at a fraction of today's price because they got to the party late, regardless of those who were here months ago and lost their collective skin by buying early. Shake the tree...
I recognize that this company has game-changer technology, but I reserve dry powder for the day that 'Cetecean Funds Ltd' finds us and decides to ride alongside as Brennan takes another startup to the big leagues (right after a bear raid). It might be short-lived, but .002's are not unthinkable between now and launch day.
"OSI has already committed $500K..."
...and it might make perfect sense for them to tell Brennan that they'd like some of those newly authorized shares in exchange for their generosity.
Concur...
There is still risk here, no doubt, but I flipped out a portion to take cash off the table in the run to .0185, so my risk is well managed. That said, I like the odds here and would be greatly disappointed if such leverage was not properly capitalized via solid management in the long run. When NAMSA and USDA are on board with the results, I tend to take notice. We didn't get there by accident.
BTW, when executives that have consistently built enterprise value in their previous ventures (all the way to the NASDAQ) waive compensation in exchange for shares that may rise or fall to zero on the open market, the idea that they don't have their own skin in the game, or that those shares are free to them, really doesn't hold up. Their time and effort are proven corporate assets, objectively and outside of this venture, so when they forgo compensation in exchange for variable insider equity, I see it as a positive. Why would people that already know how to make millions spend 10 years and 20 million on a boondoggle to make $100K?
There is ample evidence from objective sources to suggest that the MIT-1000A is highly effective and proven for a limited number of pathogens, soon to be augmented to include the Big Three. We require no FDA hamster-wheel of approval, we have a distributor network in place, and two larger companies offering manufacturing and distribution deals. The writing on the wall seems clear enough to me.
And I just might sell you some shares @ .50...
"survived 10 years on less than 100,000 in product sales..."
Yes, and they did it with the principal officers putting close to 20M of their own cash on the line to advance this technology. Ask yourself (A) How did they end up with those millions? (B) Why are they willing to invest their own capital with this venture? and (C) Have those officers had successes in the past that might clue one in as to the likelihood of them knowing more than message board doubters?
Reading Is Fundamental, and it goes beyond balance sheets. Look at the people holding the majority interests and the companies they have in their past.
And yes, I have checked the edgar filings. For a company to have come this far with such paltry resources says a lot about their management. Some of us read those filings when the shares were in the .20+ range, then watched until they could be bought for .0016. Flip a few piles and one can be sitting pretty with many free shares, waiting patiently for Brennan to get his cash back in appreciated shares as MMTC phases in large-scale production...
"Competitors already have it beat..."
Name one.
Just typing...
IF the folks at HDI wanted to check out BH, having their NAK subsidiary perform ZTEM analysis would be easy, as they are already in the area, well connected, and currently under obligation to spend money on LBSR claims anyway.
And IF they wanted to keep it under wraps, keeping the ZTEM data in-house would give Briscoe the perfect excuse to not file any material event requirements. It's NAK's data at this point, but of course it would be available to HDI and anyone else in the PLP they might wish to include in negotiations...
So it may make perfect sense that the ZTEM is not in our hands. That certainly doesn't mean that Briscoe or some board members have not heard informally about the results. It could be very handy to have a non-finalized JV partner handle the data precisely to avoid any legal obligation to divulge such information publicly. MLV may have also acted as a legal buffer in this respect.
I won't be surprised if a huge fish bites at this company, but I will be very happy.
"This will be a little negative..."
Good; I have some dry powder left for the residuals of this astute prognostication.
"stock is all time low"
I'm not always wild about the speculation, good or bad, but your words are simply non-factual. The current PPS is up over 1000% from the real lows in the double-oughts.
Some of us still value words for their literal content.
"HIGH cards are the MO of HDI..."
I appreciate your assessment. ZTEM may have revealed to Thiessen that the numbers are eventually saying to pay Briscoe and go with the economically-advantageous and removed-from-Pebble claims. If so, the most recent 8K possibly revealed this sentiment, albeit with the proverbial 'poker face'.
Projecting economic feasibility of claims is very tricky engineering. Many factors are involved, and many can change through the interim. To secure 6-7X the inferred assets, on lands beyond the zone of contention, with the team that grabbed the 'real' claims right under your nose, is just good business in this case. Grabbing the "high cards" requires a keen grasp of the real logic, up-to-and-including putting your world-class, proven claims on the back burner and developing a much larger adjacent claim via JV.
And who better to facilitate such an arrangement than our old friend JB. We (shareholders-JB included) will look pretty smart and damn lucky if we are aligned with such logic when the chips fall...
Wait for it...
"not inclined to believe that Anglo has even heard of us."
Funny, I could have sworn they were a controlling-interest partner in PLP with NAK, the company that publicly announced the JV earn-in with LBSR last summer. It would be a huge breach of duties for them to ignore the money being spent by partners in the JV with LBSR, as such engagement could certainly affect the Anglo shareholders by proxy.
I guarantee there are plenty of people in Anglo American that know exactly who LBSR is, and what their claims entail. I'm not saying they will jump at a JV with a junior, but it is their job to know where the goodies are hidden. They didn't get that 30B market cap by stepping in dog piles.
Take a look at their PPS. Makes me covet thy neighbor's goods, if you know what I mean...
http://finance.yahoo.com/q?s=AAL.L&ql=1
"How does a stock not make a move...?"
It might be because much of the market is aware of a competitor making major advances. I have watched KBLB for a while, but initial DD showed several viable competitors, including some seeking a synthetic approach that I view as having a long-term competitive edge over mass production via domesticated insects.
Here is a link to the recent news. I suspect that KBLB may have run the recent PR as a reaction to the attention given Amsilk after their announcement.
http://www.thelocal.de/sci-tech/20110913-37547.html
"So, EVERYONE - analysis and speculation time"
I have a hard time seeing this as good news without further specific info. If BH was great shakes, NAK would not have excluded further work there.
I'm sure someone is willing to guess that JB wrangled a way to have NAK pay for ZTEM at BH and then packaged a separate JV via a deep-pocket 'TBA', with the 60 day window to wrap up details. I'm willing to guess that without news of this or similar significance, the recent filing from NAK will be spun to drive the LBSR PPS into the dirt.
There is still much happening at Tombstone, etc, but until we find out that BH was mothballed for beneficial purpose of LBSR, it's not any kind of good news. Of course news to the contrary might be pending, but until we hear it in specific terms, a strategy for descending price might be in order. JMO.
"Massive Dilution" is fine...
...so long as we are printing restricted private placements to Deep Pockets. There are many reasons to increase A/S, one of which is to generate predictable operating funds while making the transition between development and production.
There are many mid/large-caps that could benefit greatly from MMTC technology. I'd be surprised if some of the big players aren't already aware of the MIT-1000.
Nice catch!
I'm betting that's a clue to something...
I was replying to SGR...
SGR posted a link to OSI's investor relations, which shows them to be a Nasdaq company.
Hand me some butter...
...because I smell toast.
"This should put a smile on everyone's faces"
Indeed, and thanks for sharing. Their Nasdaq listing means that institutional analysts and investors will be hearing about MMTC, as we become part of their revenue generation.
I like this part...
"The only items to prepare are the E. coli and Salmonella Identifiers, or database component, that should be concluded by early December."
The machine, strategic manufacturing and distribution alliances, and the vast majority of the development-stage work are all in place. Today's action looks like swing traders pouncing on yesterday's run for a retrace, plus some disappointment by those who thought they'd be buying a new Lamborghini after today's news took us "To-Da-Mooooooonnnn..."
I still like the odds here. My shares are still way up. I have dry powder if anyone wants to drag us into truly stupid prices. I've done quite well watching for just such a situation here.
Bring it on; I'll be happy to take a replay.
"...with no further liabilities to either party."
Hopefully it's not a different story for the shareholders.
"MIT1.000 is made of cardboard "
You must have seen and touched one to make such a determination. Nice to know they are in production.
And nobody is fooled by all this quasi-accidental misspelling and misnomering of Brannon/Brendan/Bronnen, or your inaccurate naming of the product. Keep trying to cast doubt while laying a flimsy case for denial, should you be contacted by authorities. It's transparent and foolish, but also serves to remind others that there is something here worth obscuring by interested parties.
My shares are free, so I won't lose a thing if this goes to zero, but it won't. I'll send you a post card from the Winner's Circle...
"I am positive of that. "
Certainty without proof is the hallmark of non-critical thinking. Feel free to post links to any documented and verifiable evidence to support your "positive" conclusions. Not your laundry list of baseless assertions which we all have seen countless times, but documented facts indicating Brennan is unloading shares.
(Cue the crickets)
"Men in Black which lead to Cowboys and Aliens"
Yes, 13 years apart, and Marvel has made several franchised series in that time, along with one-offs that will likely spur sequels, all monetized effectively via licensing.
There is money to be made here if management can hold it together and create revenue from the IP. If not, any buyout offer will be the fiscal equivalent of a mercy date.
"..purchased by disney for a cool $4 billion..."
But Marvel had been generating revenues for 50+ years and were still making money in print publishing when they began the lucrative licensing of their IP for film production. The characters and stories were pitched for decades, and to an older demographic that has money compared to the younger target audience of PDOS IP. Rosenberg has some decent content, but he would need a minimum of 20 years to give his IP the clout that Marvel had pre-Disney. That's why Marvel IP has been featured in dozens of movies, but PDOS only a few.
Still watching. Long windows between projects in this biz, i.e. long, predictable intervals for merciless shorting. Recently flipped a nice biotech, started watching it in 2009, .24 pps, bought in @.0016 last summer, watched it run 1200% on news. Patience rules in pennyland. Unless there is a serious reason to expect good news here, the bottom is still coming. I'll look at a couple more 10Q's and see what they have in the pipe that is signed and en route.
"anywhere near $1..."
My life will be debt-free again at that point. Bring it on...
"...exclusive licensing proposal..."
2M up front is nothing to sneeze at, especially given the difficulty of bringing such technology to market on a micro-cap budget.
That said, "exclusive" licensing needs to come with guarantees for MMTC shareholders, notably that a specific and sufficient amount of marketing and promotion will occur, on an agreeably and documented timeline, with a generous royalty agreement for the owners of the IP.
Anyone who knows about VC or optioning IP also knows that plenty of deals are struck for the sole purpose of limiting competition for an unnamed third party. It's why oil companies buy up alternative energy patents, or why studios option screenplays they never intend to make into movies.
I'm long here, riding freebies, so nothing to lose, but I hope this deal is what it appears and not an entanglement that will keep the MIT-1K on the back burner. It happens, and I hope it's not happening here.
Let 'em beat it like Michael Jackson...
I watched MMTC for a year before buying, and have done quite well watching for the point where the stock goes from oversold to ridiculously undervalued. Although there is some dilution to be considered since my last purchase, I still have a target bottom that I will grab with both hands when and if we get there.
I admit most of my gains are unrealized at this point, but the last few months action allowed me to make a nice grab and flip a portion for freebies, only sensible in this market. I'll do the same with a new position if some of these grim creepers have their way and get us back to absurd valuations.
Yes, yes, I know, no revenue = no valuation. This is not my first rodeo, and I have plenty of reasons to think this company can bring the shares much higher in the next few years. Anyone who thinks MMTC is getting ready to go belly-up should read the USDA and NAMSA documents, then go back and look at the backscatter modeling data in the video from last fall. If you have any idea what you're actually looking at, it's clear that the basic science and technology is in place, and the results have been confirmed independently by prestigious sources.
But go ahead and smack it down for some more double-digit losses. Dry powder awaits my target.
"...that MM does business out of the Middle East."
I believe that was a misconception. Isn't RAJA the MM for Raymond Jones Associates?
Ditto for my .0016's...
...although the last run gave me room to cash out to a free position and keep the majority, so any real dips are just buying opps for me.
Great news today. Pretty foolish to sell now, as there is plenty of upside from here.
Are we there yet...?
Okay, then knock down a bit and I'll buy some more. Smells like a gold mine to me...
"...with mining properties located in Chile"
Not so sure I'd be looking for Chilean assets to be politically stable in the near future, IMO. Recent news has been cautionary.
"The real question here is just how low..."
By all means, let's knock it down into the dirt. I can join the Million-Plus club if we drop enough.
I'll be happy to bet on Briscoe's claims against the international farce that is fiat currency. Right now I'd have to allocate an outsized percentage to hold that many shares, but if irrationally knocking the company like a whiny rhymes-with-rich allows us to buy cheapies before the real fun starts, have at it. I won't be chiming in, but buying in is another story.
So "how low" can you get it before I and the other longs start scooping up the excess?
"I'll wait till the R/S..."
It certainly happens, but they will have a lot of chances to issue and dilute along the way if that is the plan, i.e. you'll get plenty of warning.
I'm betting there is good jack to be made from this PPS, but also from the beat-down price I anticipate between now and Nov. 30.
"...share price to be devastated."
Wouldn't surprise me a bit. Maybe I'll have to buy back shares I sold to take cash off the table. Got plenty of freebies, so no risk. Today's 'news' can stir up a fresh round of hate from the folks confusing A/S & O/S, and could easily beat down the PPS from here. I already made money and acquired freebies on the last run by watching for a year and letting fear and uncertainty drive it into the ground. My .0016's look pretty sweet by today's price, as do my .002's. Gotta love Autumn; rake 'em up in a big pretty pile and wait for more to fall from the tree.
I just keep thinking about that glowing USDA report (go ahead and tell me how they send those out to all the biotechs). A friend who works in appropriations for state government looked at the MMTC data and immediately said they would line up to throw money at such a device if approved.
So go ahead and beat it like a ten-pound egg. I'll take another free ride when the next round of certs come through. Folks who make it cheaper for me to acquire a clear winner like this are my friends, although I won't be calling them up for lunch anytime soon.